Industry News
Australian biotech market watch 13/08/09
BioPharmica, Ansell, Sonic, iSOFT, Progen, pSivida [ + ]
UQ licenses hGH to PROLOR
IMBcom and PROLOR Biotech enter into technology licence for human growth hormone. [ + ]
Prognosis good for Primary Health Care
Profits up more than tenfold following acquisition of Symbion in 2008. [ + ]
Xenome adds Cherrington to board
Dr Julie Cherrington joins Xenome board as an independent, non-executive director. [ + ]
BioProspect acquisition of Re-Gen complete
Plans to expand into rapidly growing Chinese market for natural health products. [ + ]
Australian biotech market watch 07/08/09
ResMed, Ramsay, Biota, Sonic, Healthscope [ + ]
PR Australia-Japan collaboration in marine science
Marine science research is being boosted with the announcement of three joint Australian-Japan research projects.
[ + ]HIV-1 genome revealed
Big picture view of the virus's genome uncovers structures that affection function. [ + ]
Mesoblast targets heart failure in trial
Adult stem cells might eliminate the need for heart transplants in heart failure patients. [ + ]
FDA-approved manufacturing plant opens in Sydney
Facility for manufacture of highly potent sterile injectables opened by Parnell. [ + ]
Starpharma announces positive trial results
VivaGel demonstrates anti-HIV and herpes simplex virus properties. [ + ]
Australian biotech market watch 31/07/09
HeartWare, Universal Biosensors, Fisher & Paykel, CSL [ + ]
Coral genome project begins
Researchers to map genome of Australian coral, the first aquatic animal to be sequenced in this country. [ + ]
USyd is part of new formulation science project
The University of Sydney is part of The InForm project that will provide €1.7 million to boost research in formulation science.
[ + ]
